Bupe...There it is! Part I - Prescribing Basics | Palliative Care Educational Series (RECORDING)

In this recorded Palliative Care Educational Series presentation, palliative care and addiction medicine specialist Dr. Janet Ho provides a comprehensive overview on the use of buprenorphine, a partial opioid agonist, for pain management and treatment of opioid use disorder. Dr. Ho begins with an overview of buprenorphine's pharmacology, including its unique properties as a partial agonist with a strong binding affinity to the mu-opioid receptor, its ceiling effect on respiratory depression, and its ability to reduce hyperalgesia and cravings. Dr. Ho also discusses different formulations of buprenorphine in detail, including transdermal patches, buccal films, sublingual tablets, and injectable depot formulations. The appropriate dosing, titration, and administration of each formulation are explained, along with cost considerations. She also covers strategies for managing acute pain in patients already taking buprenorphine, such as splitting doses or adding a full opioid agonist like morphine or hydromorphone. Case studies are presented to illustrate the practical application of buprenorphine in various clinical scenarios. In her lecture, Dr. Ho aims to equip healthcare professionals with the knowledge and skills to effectively incorporate buprenorphine into their practice for pain management and harm reduction in patients with opioid use disorder.

Learning Objectives

At the conclusion of this activity, learners should be able to:

  1. Provide an overview of buprenorphine's unique pharmacological properties
  2. Discuss the various formulations of buprenorphine approved for pain management and opioid use disorder treatment
  3. Provides guidance on appropriate dosing and administration of buprenorphine formulations
  4. Discuss strategies for managing acute pain in patients already taking buprenorphine
  5. Utilize the available resources, such as the buprenorphine task force, phone-a-friend support, and e-consult services, for guidance and advice on buprenorphine prescribing and management

Additional Information

Partner: 
Stanford Medicine
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
Course opens: 
06/25/2024
Course expires: 
06/24/2027
Rating: 
0

Available Credit

  • 1.00 AMA PRA Category 1 Credit
Please login or register to take this course.

This course is offered through Stanford Medicine.

To take this course you will be redirected to Stanford Medicine website. You must login or create an account with Stanford Medicine in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch